EUVIMEDEUVIMED entdecken
Crossref

Theophylline Clearance in Obese Patients in Relation to Smoking and Congestive Heart Failure

R L Slaughter, R A Lanc

Drug Intelligence & Clinical Pharmacy · 1983-04 · 17 (4) · 274-276

DOI: 10.1177/106002808301700406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Intelligence & Clinical Pharmacy, online erschienen am 01.04.1983. Verfasst von R L Slaughter und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Smoking. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effect of obesity on the total body clearance (Cl tot ) of theophylline was evaluated in nonsmokers and smokers with and without congestive heart failure (CHF). The obese patients were compared with similar nonobese subjects with regard to age, sex, and disease state. The total patient population numbered 150 adults. Cl tot of theophylline, based on total body weight (TBW), averaged 0.60 ± 0.20 ml/min/kg in obese nonsmokers and did not differ from the nonobese, nonsmoking group. In obese nonsmoking patients with CHF, Cl tot based on TBW was 0.40 ± 0.14 ml/min/kg, which was similar to Cl tot values in nonsmoking CHF patients who were not obese. A trend toward a reduction in Cl tot , based on TBW, as TBW increased, in nonsmoking patients with and without CHF, was observed. In contrast to the Cl tot in nonsmokers, the Cl tot of theophylline in obese smokers with and without CHF was similar to the Cl tot values in nonobese populations only when based on ideal body weight. However, when compared with nonsmoking, nonobese patients, no differences were observed when Cl tot was corrected for TBW. These findings suggest that theophylline maintenance dose can be based on TBW in obese patients who are smokers and nonsmokers (with and without CHF), using the average Cl tot obtained for the nonsmoking patients with and without CHF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SmokingAdultAgedBody WeightFemaleHeart FailureHumansMaleMetabolic Clearance RateMiddle AgedObesityTheophylline

Substanzen

Theophylline

Zitieren

APA

Slaughter, R. L., & Lanc, R. A. (1983). Theophylline Clearance in Obese Patients in Relation to Smoking and Congestive Heart Failure. Drug Intelligence & Clinical Pharmacy, 17(4), 274-276. https://doi.org/10.1177/106002808301700406

Vancouver

Slaughter RL, Lanc RA. Theophylline Clearance in Obese Patients in Relation to Smoking and Congestive Heart Failure. Drug Intelligence & Clinical Pharmacy. 1983;17(4):274-276. doi:10.1177/106002808301700406

BibTeX
@article{Slaughter1983,
  author = {Slaughter, R L and Lanc, R A},
  title = {Theophylline Clearance in Obese Patients in Relation to Smoking and Congestive Heart Failure},
  journal = {Drug Intelligence & Clinical Pharmacy},
  year = {1983},
  volume = {17},
  number = {4},
  pages = {274--276},
  doi = {10.1177/106002808301700406}
}
Kostenlos starten →